Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
Authors
Keywords
-
Journal
PROSTATE
Volume 80, Issue 4, Pages 336-344
Publisher
Wiley
Online
2020-01-04
DOI
10.1002/pros.23948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression
- (2018) Divya Duscharla et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation
- (2018) Kenichiro Ishii et al. PROSTATE
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- A role for paracrine interleukin‐6 signaling in the tumor microenvironment in prostate tumor growth
- (2018) Shu‐Han Yu et al. PROSTATE
- Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
- (2017) Zoila Lopez-Bujanda et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Neutrophils in cancer: prognostic role and therapeutic strategies
- (2017) Alberto Ocana et al. Molecular Cancer
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer
- (2016) Xiaotao Yin et al. MEDICINE
- Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
- (2015) K L Mahon et al. BRITISH JOURNAL OF CANCER
- A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells
- (2015) S.-H. Yu et al. Cancer Immunology Research
- A Peripheral Circulating TH1 Cytokine Profile Is Inversely Associated with Prostate Cancer Risk in CLUE II
- (2014) N. A. Bhavsar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival
- (2014) Jaya Sharma et al. PROSTATE
- Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group
- (2013) Fernando Calais da Silva et al. EUROPEAN UROLOGY
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- (2013) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells
- (2013) Chengfei Liu et al. PROSTATE
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- (2012) Juanita M. Crook et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer
- (2011) Daniel J. Zabransky et al. PROSTATE
- Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy
- (2009) Toni K. Choueiri et al. CANCER
- A Double-Blind Randomized Crossover Study of Oral Thalidomide Versus Placebo for Androgen Dependent Prostate Cancer Treated With Intermittent Androgen Ablation
- (2009) William D. Figg et al. JOURNAL OF UROLOGY
- Th17 cells in human disease
- (2008) Laura A. Tesmer et al. IMMUNOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now